Candida V.
- Country
- Italy
- Department
- Ematologia
Research Overview
- Evaluation of Adverse Events, Pharmacokinetics, and Disease Activity of Oral ABBV-101 in Adult Patients with Select B-Cell Malignancies
- Efficacy and Safety Comparison of Obinutuzumab-Venetoclax vs. Obinutuzumab-Chlorambucil in Untreated CLL with Comorbidities
- Efficacy and Safety Evaluation of Venetoclax and Obinutuzumab Retreatment in Patients with Recurrent Chronic Lymphocytic Leukemia
Data & Insights
Has run more than one trial at 170 of 369 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), with extensive experience in evaluating novel therapeutic approaches for these conditions.
- BTK Inhibitor Therapies
- BCL-2 Inhibitor Applications
- Combination Treatment Strategies
Particular focus on developing treatment protocols for both treatment-naïve and relapsed/refractory patients.
Specialized Lymphoma Care
Active involvement in treating marginal zone lymphoma and related lymphoid malignancies, with expertise in novel immunotherapy approaches and targeted treatments.
- Monoclonal Antibody Therapies
- Immunomodulatory Treatments
- Rituximab-Based Protocols
Emphasis on developing personalized treatment strategies for lymphoma patients.
Autoimmune Complications
Expertise in managing autoimmune hemolytic anemia and secondary immunodeficiencies associated with hematologic conditions.
- Novel Immunotherapy Approaches
- Infection Prevention Protocols
- Management of Immune Complications
Special interest in the intersection of autoimmune disorders and blood cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.